fluoxetine has been researched along with favipiravir in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Honkimaa, A; Hyƶty, H; Sioofy-Khojine, AB | 1 |
Bamford, A; Booth, C; Breuer, J; Cheng, I; Chetty, K; Gonzalez-Granado, LI; Kaliakatsos, M; Klapsa, D; Martin, J | 1 |
2 other study(ies) available for fluoxetine and favipiravir
Article | Year |
---|---|
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
Case report: Novel treatment regimen for
Topics: Amides; Antiviral Agents; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Fluoxetine; Humans; Immunoglobulins, Intravenous; Infant; Male; Pyrazines | 2022 |